A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)
Public ClinicalTrials.gov record NCT04662151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability Profile of Intervention With AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)
Study identification
- NCT ID
- NCT04662151
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Airway Therapeutics, Inc.
- Industry
- Enrollment
- 37 participants
Conditions and interventions
Conditions
Interventions
- AT-100 Biological
- Air-sham Procedure
Biological · Procedure
Eligibility (public fields only)
- Age range
- 0 Minutes to 96 Hours
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2021
- Primary completion
- Aug 13, 2023
- Completion
- May 28, 2024
- Last update posted
- Jul 2, 2024
2021 – 2024
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Airway Therapeutics Investigational Site | Tucson | Arizona | 85724 | — |
| Airway Therapeutics Investigational Site | Little Rock | Arkansas | 72202 | — |
| Airway Therapeutics Investigational Site | Los Angeles | California | 90017 | — |
| Airway Therapeutics Investigational Site | Miami | Florida | 33143 | — |
| Airway Therapeutics Investigational Site | Atlanta | Georgia | 30308 | — |
| Airway Therapeutics Investigational Site | Indianapolis | Indiana | 46202 | — |
| Airway Therapeutics Investigational Site | Boston | Massachusetts | 02215 | — |
| Airway Therapeutics Investigational Site | Durham | North Carolina | 27705 | — |
| Airway Therapeutics Investigational Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04662151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04662151 live on ClinicalTrials.gov.